微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2025-09-30 | -0.7% | -119.13% | -70.73% | 110/158 | 1.25% | 兴齐眼药 | 32.91% | 行业排名> |
| 2025-06-30 | -0.41% | -122.16% | -286.36% | 108/158 | 0.28% | 翰宇药业 | 18.95% | 行业排名> |
| 2024-12-31 | 0.22% | -92.76% | -93.99% | 101/158 | -9.6% | 翰宇药业 | 11.39% | 行业排名> |
| 2024-09-30 | 3.66% | -6.39% | 97.84% | 75/158 | 4.24% | 百利天恒 | 181.27% | 行业排名> |
| 2024-06-30 | 1.85% | -22.92% | -39.14% | 86/158 | 2.68% | 百利天恒 | 186.1% | 行业排名> |
| 2023-12-31 | 3.04% | -40.04% | -22.25% | 79/158 | -1% | 百利天恒 | 186.89% | 行业排名> |
| 2023-09-30 | 3.91% | 134.13% | 62.92% | 82/158 | 2.35% | 百利天恒 | 188.56% | 行业排名> |
| 2023-06-30 | 2.4% | 216.5% | 515.38% | 76/158 | 1.47% | 小方制药 | 41.8% | 行业排名> |
| 2023-03-31 | 0.39% | 117.03% | -92.31% | 111/158 | 1.37% | 拓新药业 | 20.51% | 行业排名> |
| 2022-12-31 | 5.07% | -40.77% | 203.59% | 74/158 | 0.72% | 拓新药业 | 19.87% | 行业排名> |
| 2022-09-30 | 1.67% | -71.36% | 181.07% | 98/158 | 2.84% | 拓新药业 | 19.91% | 行业排名> |
| 2022-06-30 | -2.06% | -177.15% | -124.07% | 123/158 | 2.19% | 小方制药 | 55.57% | 行业排名> |
| 2021-12-31 | 8.56% | -3.6% | 46.83% | 51/158 | 0.79% | 福元医药 | 25.41% | 行业排名> |
| 2021-09-30 | 5.83% | -13.88% | 118.35% | 68/158 | 4.44% | 小方制药 | 34.81% | 行业排名> |
| 2021-06-30 | 2.67% | 128.21% | -69.93% | 84/158 | 2.97% | 退市金泰 | 10.74% | 行业排名> |
| 2020-12-31 | 8.88% | -58.62% | 31.17% | 65/158 | 3.66% | ST人福 | 6.82% | 行业排名> |
| 2020-09-30 | 6.77% | 2% | 478.63% | 60/158 | 3.07% | 小方制药 | 71.99% | 行业排名> |
| 2020-06-30 | 1.17% | -85.34% | 151.09% | 97/158 | 4.23% | 汇宇制药 | 39.25% | 行业排名> |
| 2020-03-31 | -2.29% | 2% | -110.67% | 103/158 | 2.2% | 汇宇制药 | 28.14% | 行业排名> |
| 2019-12-31 | 21.46% | 148.67% | 168.92% | 18/158 | 2.57% | 哈三联 | 27.17% | 行业排名> |
| 2019-06-30 | 7.98% | 2% | -7.53% | 25/158 | 5% | 汇宇制药 | 55.94% | 行业排名> |
| 2018-12-31 | 8.63% | 62.22% | 62.22% | 59/158 | 7.17% | 河化股份 | 45.32% | 行业排名> |
| 2017-12-31 | 5.32% | -60.06% | -60.06% | 82/158 | 9.68% | 汇宇制药 | 31.9% | 行业排名> |
| 2016-12-31 | 13.32% | 2% | 2% | 40/158 | 6.22% | 誉衡药业 | 35.56% | 行业排名> |